SIResearcher profile · from public sources
Shinsuke Iida
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010).
Blood cancer journal, Nov 2026
Publication
Distinct Clinical Features of Multiple Myeloma With t(11;14): A Post Hoc Analysis of JSH-MM-15 Study.
Cancer science, Oct 2026
Publication
Assessment of Predictive Factors That Shorten Duration of Treatment in Patients With Multiple Myeloma Using AI: Real-World Longitudinal Study Using Data From Medical Data Vision Claims Database.
JMIR cancer, Feb 2026
Publication
Correction: JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM).
International journal of hematology, Jan 2026
Publication
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Dec 2025
Publication
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Dec 2025
Publication
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma.
Blood cancer journal, Dec 2025
Publication
Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma.
Cancer science, Nov 2025
Publication
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM).
International journal of hematology, Aug 2025
Publication
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 2. Related disorders of multiple myeloma.
International journal of hematology, Aug 2025
Publication
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.
Blood, Dec 2024
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Nizar J Bahlis directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error